Ref ID: 18402
Author:
Amit Adlakha, Rishi Gupta, Arun Sebastian, Paul Tait, James Jackson,
Philip Ind1.
Author address:
Department of Thoracic Medicine, Hammersmith Hospital, London,
United Kingdom; Department of Radiology, Hammersmith Hospital, London,
United Kingdom
Full conference title:
European Respiratory Congress
Abstract:
Background: BAE for massive haemoptysis is potentially life-saving with low
short-to-medium term failure rates in previous studies. We aimed to characterise
patients referred for BAE, to examine long-term treatment success and identify
risk factors for requiring repeat BAE.
Methods: We retrospectively identified all patients undergoing BAE from 1994-
2007.We collated data from hospital databases and primary care on demographics,
respiratory diagnoses and procedure with follow-up of up to 16 years. Outcomes
were all-cause mortality and recurrence of haemoptysis requiring repeat BAE.
Results: 158 patients were embolised on 208 occasions. 85 (54%) patients were
male and median age was 54 (IQR: 41-67)y. The most common underlying diagnoses
were aspergilloma (n=38; 24% of patients), bronchiectasis (n=24; 15%),
unidentified cause (n=17; 11%) chronic tuberculosis (n=14; 9%), active tuberculosis
(n=12; 8%) and cystic fibrosis (n=11; 7%). All-cause mortality at 1 month
and 3 years was 5.3% and 29.7%, and need for repeat BAE was 4.7% and 30.7%
respectively. Repeat BAE at 3 years was most common with aspergilloma (50%)
and least common with active TB (0%). 3-year mortality was highest in cystic
fibrosis (40%) and least with unknown cause (7.7%) Neither number nor location
of vessels embolised predicted mortality or need for repeat BAE. No major
procedural complications were noted.
Conclusions: BAE by experienced operators is a safe, minimally invasive procedure
for massive haemoptysis with excellent short-term success. It does not prevent
late recurrence of haemoptysis nor obviate the need for repeat BAE, the risk of
which is related to the underlying disease rather than to technical aspects of the
procedure.
Abstract Number: P619
Conference Year: 2011
Link to conference website: http://www.ers-education.org/ersMade/abstract_print_11/files/Abstract_book_2011.pdf
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a